|
|
|
|
|
by xienze
2233 days ago
|
|
The problem with talking about per capita testing numbers is that having a bigger population means you need a proportionally larger number of tests to administer to reach the same numbers as smaller countries. The will to test and the money to do so aren’t any issue. The problem is that we can’t just snap our fingers and make tens of millions of tests appear out of thin air. I think this point gets lost on a lot of people when they look at the corona scoreboard (likewise, people fixate on the large number of deaths in the US and ignore that we’re doing better than several European nations on a deaths per million basis). |
|
You are correct - but we (or rather the government) can snap it's fingers and compel some private companies that are well positioned to be able to manufacture tests to do so at a higher priority than other business concerns - or we (again the government) can issue generous contracts for testing supplies that guarantees payment to private companies manufacturing them even if the original quota of tests requested by the government is above the level we end up needing.
I think that large countries actually have an advantage here - a small country might not have any internal industry that'd be capable of manufacturing tests without heavy retooling - or that industry might be so small and specialized that scaling it up is infeasible. But even in that sort of a situation they can use market based solutions to bid on tests in a manner that motivates private companies in other countries to feel confident committing to test production - and that's only needed if there isn't any sort of altruistic world-banding-together-to-fight-the-issue effort.